SI-BONE Inc (SIBN): Market Cap to Revenue

Symbol and logo of brand SI-BONE Inc (SIBN)

SI-BONE, Inc. (SIBN) has achieved a technological breakthrough in hip surgery by developing titanium systems for minimally invasive procedures. The fundamental P/S ratio reflects the business valuation trend, with the latest parameter standing at 4.90. Growth is supported by alliances with neurosurgeons to provide physician training. Meanwhile, an exceptional body of clinical data secures the company's status as a dominant player in the minimally invasive sacral joint treatment segment.

SIBN SI-BONE Inc P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for SI-BONE Corp (SIBN)

- share price and consensus valuation forecast:
Price Performance Chart si-bone.com|SIBN - Price Target Chart
- stock exchange capitalization data:
Market Valuation SI-BONE Corp|SIBN - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share SI-BONE|SIBN - Book Capitalization|Capitalization to Book Value Ratio si-bone.com|SIBN - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient SI-BONE, Inc.|SIBN - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio SI-BONE Medical|SIBN - Company Aggregate Debts|Debts to Book Capitalization SI-BONE Corp|SIBN - Company Long-Term Debt|Company Short-Term Debt SI-BONE|Intermediate Coverage Ratio si-bone.com
- earnings and multiples data:
SIBN - Net Profit|Expected Net Profit SI-BONE, Inc.|SIBN - Price to Earnings Ratio|Forward Price to Earnings Multiple SI-BONE Inc|SIBN - Price/Earnings to Growth Multiple|EV/EBITDA Multiple SI-BONE Corp|SIBN - Operating profit EBITDA|Net earnings per share for the last four quarters SI-BONE|SIBN - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months si-bone.com|SIBN - Earnings per share growth in current year|Expected earnings per share growth for next year SI-BONE, Inc.
- issuer revenue and sales details:
SIBN - Revenue and Sales Volume|Company Expected Sales Volume si-bone.com|SIBN - Price-to-Revenue Ratio|Market Cap to Projected Revenue SI-BONE Corp
General company analysis:SIBN si-bone.com
Core merchandise of SI-BONE, Inc.

The active displacement of traditional treatment methods by innovative SI-BONE (SIBN) implants is accelerating business expansion, establishing revenue as a key value driver. The ratio of market capitalization to annual turnover measures the premium investors are willing to pay per unit of sales; therefore, the price-to-sales multiple history helps determine the extent of the asset's overvaluation relative to its commercial growth rates.

Competitors of SI-BONE, Inc.

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio Orthofix (OFIX)|Bioventus Inc (BVS) - Price-to-Revenue Multiple|OrthoPediatrics - Market Cap to Revenue|P/S Multiple Treace Corp TMCI|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|xtantmedical.com (XTNT) - Price-to-Revenue Ratio|NMTC - Price-to-Revenue Coefficient|MODD (Modular Medical Inc) - P/S Multiple|Myomo Inc. (MYO) - Price-to-Revenue Coefficient|Market Cap to Revenue COCH (Envoy Medical, Inc)|Vivos Therapeutics Inc (VVOS) - Price-to-Revenue Multiple|P/S Multiple NVNO (enVVeno Medical)|Sintx Technologies Inc - Price-to-Revenue Ratio|TNON - Price-to-Revenue Ratio|Price to Sales ReWalk Robotics|autonomix.com (AMIX) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio IVF|BBLG (Bone Biologics) - P/S Multiple|Price to Sales axonics.com AXNX|Market Cap to Revenue BIOL (BIOLASE)|DYNT (dynatronics.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple FNA (Paragon 28)|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)